Skip to main content
Clinical Trials/ACTRN12612000864820
ACTRN12612000864820
Not yet recruiting
Phase 2

A short term study of safety and glycaemic outcomes in peritoneal dialysis patients with type 2 diabetes treated with metformin

Tilenka Thynne0 sites6 target enrollmentStarted: August 15, 2012Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Tilenka Thynne
Enrollment
6

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 100 Years (—)
Sex
All

Inclusion Criteria

  • (1\)\>18 years old
  • (2\)Type 2 DM
  • (3\)Peritoneal Dialysis treatment of chronic kidney disease
  • (4\)Patients in whom metformin would be used if they had normal renal function

Exclusion Criteria

  • (1\)Any patient in whom metofrmin would not be used in the setting of normal renal function\- moderate\-severe heart failure, liver failure, alcohol abuse, major psychaitric disorder, acutely unwell or otherwise medically unstable.
  • (2\)Unability or unwilling to measure own blood glucose concentrations via glucometer.
  • (3\)Inability to provide written informed consent.

Investigators

Sponsor
Tilenka Thynne

Similar Trials